Syra Health Price to Free Cash Flow Ratio 2022-2024 | SYRA

Syra Health price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as

Syra Health Price to Free Cash Flow Ratio 2022-2024 | SYRA

Syra Health price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$37.9B
Tempus AI (TEM)$9B
Hims & Hers Health (HIMS)$8.1B
Inspire Medical Systems (INSP)$5.8B
IRhythm Technologies (IRTC)$3.4B
Privia Health (PRVA)$2.7B
Enovis (ENOV)$2.7B
Azenta (AZTA)$2.5B
Clover Health Investments (CLOV)$2.2B
Omnicell (OMCL)$2.1B
Schrodinger (SDGR)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.7B
Butterfly Network (BFLY)$850M
Standard BioTools (LAB)$577M
Talkspace (TALK)$524M
Fulgent Genetics (FLGT)$509M
TruBridge (TBRG)$370M
Nyxoah SA (NYXH)$368M
Health Catalyst (HCAT)$343M
SOPHiA GENETICS SA (SOPH)$229M
Pulmonx (LUNG)$224M
American Well (AMWL)$165M
MDxHealth SA (MDXH)$90M
EUDA Health Holdings (EUDA)$87M
P3 Health Partners (PIII)$65M
HeartBeam (BEAT)$64M
CareCloud (CCLD)$56M
111 (YI)$50M
SHL Telemedicine (SHLT)$47M